Article
Antithrombotic and Prohemorrhagic Actions of Different Concentrations of Apixaban in Patients Exposed to Single and Dual Antiplatelet Regimens
2022-12-09
Abstract excerpt
<title>Abstract</title> <p><bold>BACKGROUND:</bold> Treatment with triple antithrombotic therapies increases bleeding risks. <bold>AIM:</bold> We evaluated the antithrombotic and prohemorrhagic actions of different concentrations of apixaban (APIX) in healthy donors and patients exposed to currently used antiplatelet regimens. <bold>METHODS:</bold> 25 healthy subjects and 53 patients treated with aspirin (ASA, n=...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b22f8c4d-33c7-5272-889c-8abb6a9e026a
- DOI
- 10.21203/rs.3.rs-2320523/v1
